Biogen Licenses Immune Drug from Vanqua Bio Biogen has licensed a preclinical drug from Vanqua Bio, designed to inhibit "C5aR1", a part of the immune system that regulates inflammation.
Halo: Campaign Evolved First Impressions Halo: Campaign Evolved seems like it's going to be a stunner, but I still have a few questions af…
Remembering the Thumb Fun Haunted Mansion A discussion about the Haunted Mansion with one of the last people to work there, scaring visito…
Galamsey Fight: Significant Progress Made The Minister of State in charge of Government Communication, Felix Kwakye Ofosu, has stated that…
Nana Konadu's Passing: A Moment of National Reflection Minister of Education, Haruna Iddrisu, has described the passing of former First La…
Nana Konadu's Legacy Deputy Presidential Spokesperson Shamima Muslim described the passing of former First Lady Nana Konadu Agyeman-Rawlin…
Kia Telluride: Next-gen three-row SUV teased in the US The Kia Telluride, a sibling of the Hyundai Palisade, will make its debut next mont…
President Mahama's Plan for Persons with Disabilities President John Mahama has reaffirmed his administration's commitment to creating a m…
US Expects Flight Delays to Worsen US Transportation Secretary Sean Duffy expects more flight delays as air traffic controllers prepare to…
Pharmaceutical Executive Daily: TrumpRx's Implication on DTC Commercialization Welcome to Pharmaceutical Executive Daily, your quick brief…
Federal Workers Feel Strain of Government Shutdown Federal workers are beginning to worry about going without paychecks as the government …